Dr. Tiffany Crawford Scharschmidt, MD

Dr. Scharschmidt practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Scharschmidt's NPI, 1073760096, was assigned on August 20, 2008. Dr. Scharschmidt graduated from UCSF School of Medicine in 2008. Dr. Scharschmidt holds California license A111566.

Dr. Scharschmidt's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Scharschmidt's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Scharschmidt to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Scharschmidt practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Scharschmidt's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Scharschmidt is board certified in dermatology by the American Board of Dermatology. Dr. Scharschmidt is licensed in California.

Dmand AI lists acute skin infection, benign or precancerous skin growths, contact dermatitis, hives, itchy rashes, joint cyst, psoriasis and rash among the conditions Dr. Scharschmidt treats.

CMS data shows 556 Medicare services from Dr. Scharschmidt across 6 procedure codes in 2024, for 120 Medicare patients. Medicare paid $18,278 for them. Every service was in an office.

CMS counts 120 Medicare patients who saw Dr. Scharschmidt in 2024. The largest group is 65 to 74, with 50 patients. 63% of them have high blood pressure, and 58% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Scharschmidt's median patient age at 66, with 64% women.

In 2024, Dr. Scharschmidt wrote 523 Medicare Part D claims for 127 patients. 82% of them were for generic drugs. CMS names the drug for 390 of them, across 19 drugs with 11 or more claims each, at $459,622 in total drug cost. In 2023, CMS named 299 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Scharschmidt for performance year 2024, reported as part of a group. Dr. Scharschmidt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Scharschmidt as offering telehealth. CMS counts 208 procedures of removal of skin lesions by Dr. Scharschmidt, more than 79% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 37 papers to Dr. Scharschmidt, published from 2001 to 2025. 2018 was the busiest year, with 3. The most frequent topics are Skin, Dermatitis, Atopic and T-Lymphocytes, Regulatory. Dr. Scharschmidt has published most often in J Invest Dermatol. Dr. Scharschmidt's most frequent co-authors are Theodora M. Mauro, MD, Michael David Rosenblum, MD, PhD and Abul K. Abbas, MBBS.

CMS Open Payments shows 8 general payments to Dr. Scharschmidt from 2 drug and device companies from 2016 to 2018. Consulting fees make up the largest share, 55% of the total. Sanofi and Genzyme US Companies paid the most, $16,738.

Dr. Scharschmidt graduated from UCSF School of Medicine in 2008.

Dr. Scharschmidt is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.